MXPA04001856A - Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos. - Google Patents

Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.

Info

Publication number
MXPA04001856A
MXPA04001856A MXPA04001856A MXPA04001856A MXPA04001856A MX PA04001856 A MXPA04001856 A MX PA04001856A MX PA04001856 A MXPA04001856 A MX PA04001856A MX PA04001856 A MXPA04001856 A MX PA04001856A MX PA04001856 A MXPA04001856 A MX PA04001856A
Authority
MX
Mexico
Prior art keywords
ols
production
derivatives
medicaments
substituted indane
Prior art date
Application number
MXPA04001856A
Other languages
English (en)
Inventor
Bickel Martin
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of MXPA04001856A publication Critical patent/MXPA04001856A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/17—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/20—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Abstract

La invencion se relaciona a indan-1-oles C2-sustituidos y a sus sales fisiologicamente compatibles y derivados fisiologicamente funcionales. La invencion tambien se relaciona a compuestos de la formula (I), en donde los grupos se definen como por la descripcion, a sus sales fisiologicamente compatibles y a un metodo para la produccion de los compuestos. Los compuestos son adecuados para uso, por ejemplo, como anorexicos.
MXPA04001856A 2001-08-31 2002-08-17 Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos. MXPA04001856A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10142667A DE10142667B4 (de) 2001-08-31 2001-08-31 C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel
PCT/EP2002/009206 WO2003020696A1 (de) 2001-08-31 2002-08-17 C2-substituierte indan-1-ole und ihre derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
MXPA04001856A true MXPA04001856A (es) 2004-06-15

Family

ID=7697237

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04001856A MXPA04001856A (es) 2001-08-31 2002-08-17 Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.

Country Status (12)

Country Link
US (4) US6657086B2 (es)
EP (1) EP1425266B1 (es)
JP (1) JP4263999B2 (es)
AR (1) AR036676A1 (es)
AT (1) ATE429418T1 (es)
AU (1) AU2002333449B2 (es)
CA (1) CA2458527A1 (es)
DE (2) DE10142667B4 (es)
IL (1) IL160606A0 (es)
MX (1) MXPA04001856A (es)
PE (1) PE20030359A1 (es)
WO (1) WO2003020696A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10142663B4 (de) 2001-08-31 2004-08-19 Aventis Pharma Deutschland Gmbh C2-Disubstituierte Indan-1-ol-Systeme
DE10142666A1 (de) * 2001-08-31 2003-03-20 Aventis Pharma Gmbh Verwendung von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
CN101300006B (zh) * 2005-06-02 2012-07-25 叶林发现公司 用于治疗肥胖的mao-b抑制剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3043824A (en) * 1959-09-28 1962-07-10 Exxon Research Engineering Co Hydroperoxide and sulfoxide compounds
US3016348A (en) * 1959-11-02 1962-01-09 Universal Oil Prod Co Manufacture and use of sulfided hydrocarbon purification catalyst
US3642785A (en) * 1969-08-11 1972-02-15 Merck & Co Inc Indenyl-3-aliphatic amines
FR2201882B1 (es) * 1972-07-20 1975-10-31 Logeais Labor Jacques
GB1465794A (en) * 1974-05-17 1977-03-02 Wyeth John & Brother Ltd Thiourea derivatives
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
EP0009554B1 (de) 1978-07-27 1983-04-27 Schering Aktiengesellschaft Indanyl-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
MX13484A (es) 1987-10-19 1993-05-01 Pfizer Procedimiento para la obtencion de tetralinas, cromanos y compuestos relacionados, sustituidos
ATE246668T1 (de) 1995-12-06 2003-08-15 Venantius Ltd Dimere indan verbindungen und ihre pharmazeutische verwendung
CZ220498A3 (cs) 1996-01-17 1998-11-11 Novo Nordisk A/S Deriváty 1,2,4-thiadiazinu a 1,4-thiazinu, příprava a použití
DE19705402B4 (de) 1996-07-17 2007-04-26 Robert Bosch Gmbh Gassensor
DE69737479T4 (de) 1996-08-30 2010-05-06 Novo Nordisk A/S Glp-1 derivate
RU2200161C2 (ru) 1996-12-31 2003-03-10 Др. Редди'З Рисерч Фаундейшн Новые производные азолидиндиона, способ их получения (варианты), фармацевтические композиции на их основе, способ предупреждения или лечения, способ снижения глюкозы и промежуточное соединение
KR20010021936A (ko) 1997-07-16 2001-03-15 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 융합된 1,2,4-티아디아진 유도체, 그의 제조와 사용
FR2769312B1 (fr) * 1997-10-03 1999-12-03 Adir Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2782515B1 (fr) * 1998-08-21 2000-09-22 Adir NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
EP1078632A1 (en) 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity

Also Published As

Publication number Publication date
US7045649B2 (en) 2006-05-16
EP1425266B1 (de) 2009-04-22
US20050101798A1 (en) 2005-05-12
ATE429418T1 (de) 2009-05-15
EP1425266A1 (de) 2004-06-09
US20030114681A1 (en) 2003-06-19
IL160606A0 (en) 2004-07-25
DE10142667A1 (de) 2003-03-27
JP4263999B2 (ja) 2009-05-13
US20040068016A1 (en) 2004-04-08
AR036676A1 (es) 2004-09-29
CA2458527A1 (en) 2003-03-13
WO2003020696A1 (de) 2003-03-13
PE20030359A1 (es) 2003-05-20
US6657086B2 (en) 2003-12-02
DE50213487D1 (de) 2009-06-04
JP2005525297A (ja) 2005-08-25
US7015208B2 (en) 2006-03-21
DE10142667B4 (de) 2004-06-09
AU2002333449B2 (en) 2007-09-06
US20050113595A1 (en) 2005-05-26

Similar Documents

Publication Publication Date Title
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
RS20050019A (en) Heterocyclically substituted benzoylureas,method for their production and their use as medicaments
YU91002A (sh) Derivati acilfenil-karbamida, postupak za njihovu proizvodnju i njihova primena kao leka
BG108318A (en) Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
TNSN04199A1 (en) Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use
IL160440A (en) Dihydropteridinones, method for producing the same and the use thereof as medicaments
MY133392A (en) Novel substituted pyrazole derivatives
MY137039A (en) Thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
JO2353B1 (en) New derivatives of mixed-ring fluoroglycosides and drugs containing these compounds and their use
PL364598A1 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
JO2493B1 (en) New phenyl azatidinone with improved physical properties and methods of preparation of drugs containing it and its uses
YU56302A (sh) Derivati 8,8a-dihidro-indeno/1,2-d/taizola, koji su supstituisani u 8a-položaju,postupak za njihovu proizvodnju i njihova primena kod leka npr.kao anorektičnog sredstva
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
WO2002010152A3 (de) Neue indolderivate und deren verwendung als arzneimittel
IL166057A0 (en) Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments
WO2004106307A3 (fr) Nouveaux derives d’imidazoles, leur preparation et leur utilisation en tant que medicament
RS88704A (en) Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
MXPA04001851A (es) Inda-1-onas c2-disustituidas y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA04001846A (es) Indan-1-onas c2-substituidas y sus derivados, metodos para su produccion y su uso como medicamentos.
MXPA04001849A (es) Sistemas de indan-1-ol c2-disustituidos, metodo para su produccion y su uso como medicamentos.
WO2000076966A3 (de) Indolinylamidderivate und deren verwendung als antivirale arzneimittel
MXPA04000623A (es) Derivados de tetrahidropiridazina y su uso como pesticidas.

Legal Events

Date Code Title Description
HC Change of company name or juridical status
FG Grant or registration